Retraction: Amelioration of osteopenia and hypovitaminosis D by 1-hydroxyvitamin D3 in elderly patients with Parkinson's disease. (Journal of Neurology, Neurosurgery and Psychiatry (1999) 66 (64-68) DOI: 10.1136/jnnp.66.1.64);Amelioration of osteopenia and hypovitaminosis D by 1α-hydroxyvitamin D3 in elderly patients with Parkinson's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 66, Issue 1, 1999, Pages 64-68

  Sato, Yoshihiro ^a,c   Manabe, Seiji ^a   Kuno, Haruko ^a   Oizumi, Kotaro ^b  

^a Futase Social Insurance Hospital   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KURUME UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Osteoporosis; Parkinson's disease; Vitamin D

Indexed keywords

COLECALCIFEROL; DIHYDROXYCOLECALCIFEROL; PARATHYROID HORMONE; PLACEBO;

AGED; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FRACTURE; HIP FRACTURE; HUMAN; HYPERPARATHYROIDISM; INCIDENCE; KIDNEY; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; METACARPAL BONE; OSTEOPENIA; OSTEOPOROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; RADIODENSITOMETRY; RANDOMIZED CONTROLLED TRIAL; SERUM; VITAMIN D DEFICIENCY;

EID: 0033057160     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.66.1.64ret     Document Type: Erratum

References (30)

1. Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. N Engl J Med 1991;324:1326-31.
2. Chiu KY, Pun WK, Luk KDK, et al. Sequential fractures of both hips in elderly patients - a prospective study. J Trauma 1992;32:584-7.
3. Johnell O, Melton LJ, Atkinson IIIEJ, et al. Fracture risk in patients with parkinsonism: a population-based study in Olmsted Country, Minnesota. Age Aging 1992;21:32-8.
4. Ishizaki F, Harada T, Katayama S, et al. Relationships between osteopenia and clinical characteristics of Parkinson's disease. Mov Disord 1993;8:507-11.
5. Kao CH, Chen CC, Wang SJ, et al. Bone mineral density in patients with Parkinson's disease measured by dual photon absorptiometry. Nucl Med Commun 1994;15:173-7.
6. Coughlin L, Templeton J. Hip fractures in patients with Parkinson's disease. Clin Orthop Rel Res 1980;148:192-5.
7. Eventov I, Moreno M, Geller E, et al. Hip fractures in patients with Parkinson's syndrome. J Trauma 1983;23:98-101.
8. Staeheli JW, Frassica FJ, Sim FH. Prosthetic replacement of the femoral head of fracture of the femoral neck in patients who have Parkinson disease. J Bone Joint Surg Am 1988;70: 565-8.
9. Sato Y, Kikuyama M, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology 1997;49:1273-8.
10. Shiraki M, Ito H, Orimo H. The ultra long-term treatment of senile osteoporosis with 1α-hydroxyvitamin D3. Bone and Mineral 1993;20:223-34.
11. Shiraki M. Treatment of osteoporosis with vitamin D3. Osteoporosis Int 1993;1(supple):176-80.
12. Menczel J, Foldes J, Steinberg R, et al. Alfacalcidol (alpha D3) and calcium in osteoporosis. Clin Orthop Rel Res 1994; 300:241-7.
13. Orimo H, Shiraki M, Hayashi Y, et al. Effects of 1α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 1994;54:370-6.
14. Orimo H, Shiraki M, Hayashi T, et al. Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1α (OH)-vitamin D3. Bone and Mineral 1987;3:47-52.
15. Sato Y, Maruoka H, Oizumi K. Amelioration of hemiplegia-associated osteopenia over four years following stroke by 1α-hydroxyvitamin D3 and calcium supplementation. Stroke 1997;28:736-9.
16. Inoue T, Orimo H, Koshikawa S, et al. Acronym of improved microdensitometry (computed x ray densitometry) [letter]. Journal of Bone and Mineral Metabolism 1994; 12:145.
17. Mastumoto C, Kushida K, Yamazaki K, et al. Metacarpal bone mass in normal and osteoporotic Japanese women using computed x ray densitometry. Calcif Tissue Int 1994; 55:324-9.
18. Garnero P, Grimaux M, Seguin P, et al. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 1994;9:255-64.
19. Eriksen EF, Charles P, Melsen F, et al. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res 1993;8:127-32.
20. Koller WC, Glatt S, Vetere-Overfield B, et al. Falls and Parkinson's disease. Clin Neuropharmacol 1989;12:98-105.
21. Tilyard MW, Spears GFS, Thomson J, et al. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992;326:357-62.
22. Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-6.
23. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-42.
24. Orimo H, Inoue T, Fujita T, et al. Clinical experience with 1α-OH-D3: senile osteoporosis. In: Norman AW, Schaefer K, Herrath DV, et al, eds. Vitamin D, chemical, biochemical and clinical endocrinology of Ca metabolism. Berlin: Walter de Gruyter, 1982:1239-43.
25. Pouilles JM, Tremollieres F, Todorovsky N, et al. Precision and sensitivity of dual-energy x ray absorptiometry in spinal osteoporosis. J Bone Miner Res 1991;6:997-1002.
26. Matsumoto C, Kushida K, Sato Y, et al. The second metacarpal bone density microdensitometry method (in Japanese). Seikeigeka 1992;43:1140-6.
27. Derisquebourg T, Dubois P, Devogelaer JP, et al. Automated computerized radiogrammetry of the second metacarpal and its correlation with absorptiometry of the forearm and spine. Calcif Tissue Int 1994;54:461-5.
28. Wimalawansa SJ. Long-and short-term side effects and safety of calcitonin in man: a prospective study. Calcif Tissus Int 1993;52:90-3.
29. Carano A, Teitelbaum SL, Konsek JD, et al. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 1990;85:456-61.
30. Strom T, Steiniche T, Thamsborg G, et al. Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis. J Bone Miner Res 1993;8:199-208.